Analysen von Andrew S. Baum
| 03.12.12 | Pfizer buy | Citigroup Corp. | |
| 25.10.12 | Bayer buy | Citigroup Corp. | |
| 16.10.12 | Novartis neutral | Citigroup Corp. | |
| 16.10.12 | Bayer buy | Citigroup Corp. | |
| 14.09.12 | GSK buy | Citigroup Corp. | |
| 29.08.12 | Novartis neutral | Citigroup Corp. |